Abrocitinib and dupilumab bridging therapy for bullous pemphigoid with insufficient response to initial corticosteroid therapy: a case report. [PDF]
Zhang H, Li L, Zhao S, Wu H, Zhu J.
europepmc +1 more source
Comment on "Cancer Treatment Modalities and Female Fertility Preservation". [PDF]
Balkar ME.
europepmc +1 more source
Evolving CRBN ligands enhance the drug-like properties of protein degraders. [PDF]
Ji XQ, Wang L, Dai XJ.
europepmc +1 more source
Clinical Insights into <i>RELA</i>-Associated Disease: From Genotype to Phenotype and Exploring Treatment. [PDF]
Pan C +5 more
europepmc +1 more source
Thalidomide memorial activity: pedagogies of creativity, joy and immersion in medical education. [PDF]
Joshi A, Prajapati D, Parmar K.
europepmc +1 more source
Cereblon upregulation overcomes thalidomide resistance in multiple myeloma through mitochondrial functional reprogramming. [PDF]
Marquez J +10 more
europepmc +1 more source
Identification and Studies of Highly Potent and Selective Heterobifunctional Galectin‑3 Degraders. [PDF]
Liu C +17 more
europepmc +1 more source
How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women. [PDF]
Falci M.
europepmc +1 more source
Efficacy and safety of spesolimab in resistant pyoderma gangrenosum: a case report and brief review of the literature. [PDF]
Turki K +9 more
europepmc +1 more source
Corrigendum to "pH-driven butterfly effect for cascade-amplified tumor therapy based on thalidomide coordinated Fe-HMME nanoplatform" [Mater. Today Bio, 32 (2025) 101691]. [PDF]
Qu B +7 more
europepmc +1 more source

